Article Text

Download PDFPDF
New developments in the treatment of type 1 diabetes in children

Statistics from Altmetric.com

Footnotes

  • Competing interests: Although all authors have previously received honoraria for speaking engagements or research support from various pharmaceutical and device companies in the diabetes field, we do not have any competing interests to declare regarding the present manuscript.

  • Abbreviations:
    CSII
    continuous subcutaneous insulin infusion
    DCCT
    Diabetes Control and Complications Trial
    EDIC
    Epidemiology of Diabetes Interventions and Complications
    GLP-1
    glucagon-like peptide 1
    MDI
    multiple daily injections
    NPH
    neutral protamine Hagedorn

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.